MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, IMRA has $503,887K in assets. $15,415K in debts. $119,437K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
3258.31%
Cash Ratio
785.20%
Debt to Asset Ratio
3.06%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other long-term assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-06-30
Property and equipment, net
462
Restricted cash
0
Prepaid expenses and other current assets
5,119
Marketable securities
371,066
Cash and cash equivalents
119,437
Total current assets
495,622
Other long-term assets
7,239
Operating lease right-of-use assets
564
Total assets
503,887
Accrued expenses and other current liabilities
12,860
Accounts payable
2,351
Total current liabilities
15,211
Long-term liabilities
204
Total liabilities
15,415
Accumulated deficit
-297,351
Common stock, par value 0.001 authorized shares - 100,000,000 issued and outstanding shares - 59,226,171 and 48,936,459 at june 30, 2025 and december 31, 2024, respectively
59
Additional paid-in capital
785,941
Accumulated other comprehensive (loss) income
-177
Total stockholders' equity
488,472
Total liabilities and stockholders' equity
503,887
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$119,437K Marketable securities$371,066K Prepaid expenses andother current assets$5,119K Operating leaseright-of-use assets$564K Other long-termassets$7,239K Total current assets$495,622K Property and equipment,net$462K Total assets$503,887K Total liabilities andstockholders' equity$503,887K Total stockholders'equity$488,472K Total liabilities$15,415K Accumulated othercomprehensive (loss) income-$177K Accumulated deficit-$297,351K Additional paid-in capital$785,941K Long-term liabilities$204K Total currentliabilities$15,211K Common stock, par value0.001 authorized...$59K Accounts payable$2,351K Accrued expenses andother current...$12,860K

Enliven Therapeutics, Inc. (IMRA)

Enliven Therapeutics, Inc. (IMRA)